With the cancer center’s corporate ties under scrutiny, the hospital told employees that no one should profit personally from representing MSK on outside boards.
from NYT > Technology https://ift.tt/2IpPvlz
Sep 29, 2018
Home
/
NYT > Technology
/
Technology
/
Sloan Kettering Executive Turns Over Windfall Stake in Biotech Start-Up
Sloan Kettering Executive Turns Over Windfall Stake in Biotech Start-Up
Technology
Labels:
NYT > Technology,
Technology
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment